{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:25:17Z","timestamp":1792409117852,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013672","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000}}],"reference-count":63,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013672.pub2","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:29:43Z","timestamp":1757330983000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Opioid agonist therapy for opioid use disorder in primary versus specialty care"],"prefix":"10.1002","volume":"2025","author":[{"given":"Danielle","family":"Perry","sequence":"additional","affiliation":[{"name":"College of Family Physicians of Canada; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica EM","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Radius Community Health and Healing (formerly Boyle McCauley Health Centre); Edmonton, Alberta Canada"},{"name":"Department of Family Medicine; University of Alberta; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa L","family":"Doroshuk","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kelmer","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S","family":"Korownyk","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Ton","sequence":"additional","affiliation":[{"name":"Alberta Blue Cross; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-2158","authenticated-orcid":false,"given":"Scott R","family":"Garrison","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; University of Alberta; Edmonton, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD013672.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"e112328","DOI":"10.1371\/journal.pone.0112328","article-title":"Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville)","volume":"9","author":"Carrieri","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0002|cit2","unstructured":"Initialization of methadone in primary care, randomized intervention research for preventing HCV transmission practices (Methaville) https:\/\/clinicaltrials.gov\/study\/NCT00657397"},{"issue":"14","key":"10.1002\/14651858.CD013672.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.286.14.1724","article-title":"Methadone maintenance in primary care: a randomized controlled trial","volume":"286","author":"Fiellin","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD013672.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jsat.2006.05.014","article-title":"A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model","volume":"31","author":"King","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"10.1002\/14651858.CD013672.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial","volume":"152","author":"Lucas","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"107690","DOI":"10.1016\/j.cct.2024.107690","article-title":"Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine","volume":"146","author":"Machavariani","year":"2024","journal-title":"Contemporary Clinical Trials"},{"issue":"11","key":"10.1002\/14651858.CD013672.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e0000344","DOI":"10.1371\/journal.pgph.0000344","article-title":"Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: a randomized control trial","volume":"2","author":"Pashchenko","year":"2022","journal-title":"PLOS Global Public Health"},{"issue":"2","key":"10.1002\/14651858.CD013672.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O'Connor","year":"1998","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013672.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.adt.0000210713.80198.d1","article-title":"Safety, efficacy, and feasibility of office-based prescribing and community pharmacy dispensing of methadone","volume":"5","author":"Tuchman","year":"2006","journal-title":"Addictive Disorders and Their Treatment"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.20471\/apr.2017.53.01.02","article-title":"The differences in quality of life between the heroin addicts treated in methadone program and addicts treated in the Frame of Therapeutic Community Program","volume":"53","author":"Bevanda","year":"2017","journal-title":"Alcohol and Psychiatric Research"},{"issue":"2","key":"10.1002\/14651858.CD013672.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/095952304100017044154","article-title":"A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal","volume":"23","author":"Doran","year":"2004","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0012|cit12","first-page":"55","article-title":"Office versus narcotic treatment program-based buprenorphine for opioid dependence","volume":"66","author":"Fiellin","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5694\/j.1326-5377.2003.tb05417.x","article-title":"A comparison of buprenorphine treatment in clinic and primary care settings: a randomized trial","volume":"179","author":"Gibson","year":"2003","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0014|cit14","unstructured":"Methadone maintenance treatment for opiate addicts in shared care: is it effective in improving health outcomes and reducing criminality? A randomized controlled trial in a new primary care clinic https:\/\/www.isrctn.com\/ISRCTN58665373"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J465v28n02_02","article-title":"Women and opioid dependence treatment: office-based versus opioid treatment program-based care","volume":"28","author":"Jones","year":"2007","journal-title":"Substance Abuse"},{"issue":"10","key":"10.1002\/14651858.CD013672.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1176\/appi.ajp.21090964","article-title":"Flexible buprenorphine\/naloxone model of care for reducing opioid use in individuals with prescription-type opioid use disorder: an open-label, pragmatic, noninferiority randomized controlled trial","volume":"179","author":"Jutras-Aswad","year":"2022","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013672.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s13063-021-05698-4","article-title":"Bridging recovery initiative despite gaps in entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder","volume":"22","author":"Marcovitz","year":"2021","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD013672.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ADM.0b013e318233d621","article-title":"Comparison of buprenorphine treatment for opioid dependence in 3 settings","volume":"6","author":"Miotto","year":"2012","journal-title":"Journal of Addiction Medicine"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0019|cit19","unstructured":"Medication maintenance therapy in community pharmacy settings https:\/\/clinicaltrials.gov\/study\/NCT04139213"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2458-12-488","article-title":"Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial","volume":"12","author":"Roux","year":"2012","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1002\/14651858.CD013672.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/add.15954","article-title":"Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine\/naloxone among people with prescription-type opioid use disorder: secondary analysis of Canadian treatment trial","volume":"117","author":"Socias","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD013672.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1186\/s12913-022-08915-1","article-title":"Baseline representativeness of patients in clinics enrolled in the primary care opioid use disorders treatment (PROUD) trial: comparison of trial and nontrial clinics in the same health systems","volume":"22","author":"Wartko","year":"2022","journal-title":"BMC Health Services Research"},{"issue":"10","key":"10.1002\/14651858.CD013672.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jamainternmed.2017.3947","article-title":"Collaborative care for opioid and alcohol use disorders in primary care: the SUMMIT randomized clinical trial","volume":"177","author":"Watkins","year":"2017","journal-title":"JAMA Internal Medicine"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0024|cit24","unstructured":"Drucker E Hartel D Tuchman E Office-based methadone prescribing in primary care: preliminary results of a randomized clinical trial of safety and efficacy 62nd Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.; 2000 Jun 17-22; San Juan (Puerto Rico) 2000"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0025|cit25","unstructured":"Ling W Cunningham-Rathner J Miotto K Cantu CL Pearce V Maya S Treatment settings in evaluation of buprenorphine\/naloxone combination tablet for the treatment of opiate dependence 63rd Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.; 2001 Jun 16-21; Scottsdale (Arizona) 2001"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0026|cit26","unstructured":"Primary care https:\/\/www.aafp.org\/about\/policies\/all\/primary-care.html"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0027|cit27","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"7","key":"10.1002\/14651858.CD013672.pub2-BIB0028|cit28","first-page":"1","article-title":"Drug overdose mortality by usual occupation and industry: 46 US states and New York City, 2020","volume":"72","author":"Billock","year":"2023","journal-title":"National Vital Statistics Reports"},{"issue":"5","key":"10.1002\/14651858.CD013672.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0030|cit30","unstructured":"Centers for Disease Control and Prevention CDC reports nearly 24% decline in US drug overdose deaths; 25 February 2025 https:\/\/www.cdc.gov\/media\/releases\/2025\/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html"},{"issue":"1","key":"10.1002\/14651858.CD013672.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12875-024-02607-x","article-title":"Reframing conceptualizations of primary care involvement in opioid use disorder treatment","volume":"25","author":"Chiu","year":"2024","journal-title":"BMC Primary Care"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0032|cit32","unstructured":"Canadian Institute for Health Information Primary care https:\/\/www.cihi.ca\/en\/topics\/primary-care"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0033|cit33","unstructured":"European Union Drugs Agency Drug-induced deaths \u2014 the current situation in Europe (European Drug Report 2024) https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024\/drug-induced-deaths_en"},{"issue":"3","key":"10.1002\/14651858.CD013672.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2014 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0035|cit35","unstructured":"About opioids https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/about-opioids.html"},{"issue":"8","key":"10.1002\/14651858.CD013672.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004145.pub4","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013672.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub5","article-title":"Buprenorphine for managing opioid withdrawal","author":"Gowing","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7650","key":"10.1002\/14651858.CD013672.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD013672.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bja.2018.03.009","article-title":"Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis","volume":"120","author":"Higgens","year":"2018","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0040|cit40","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0041|cit41","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013672.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FTD.0000000000000817","article-title":"The North American opioid epidemic","volume":"43","author":"Jannetto","year":"2021","journal-title":"Therapeutic Drug Monitoring"},{"issue":"8","key":"10.1002\/14651858.CD013672.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"e2327488","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1002\/14651858.CD013672.pub2-BIB0044|cit44","first-page":"321","article-title":"Managing opioid use disorder in primary care: PEER simplified guideline","volume":"65","author":"Korownyk","year":"2019","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/YCO.0000000000000712","article-title":"The opioid overdose crisis as a global health challenge","volume":"34","author":"Krausz","year":"2021","journal-title":"Current Opinion Psychiatry"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/add.16178","article-title":"Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002\u201317","volume":"118","author":"Larney","year":"2023","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD013672.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0048|cit48","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies (chapter last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD013672.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus non opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013672.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013672.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","volume":"368","author":"Pearce","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD013672.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012021.pub2","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","author":"Platt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0054|cit54","unstructured":"Public Health Agency of Canada Substance-related Overdose and Mortality Surveillance Task Group on behalf of the Council of Chief Medical Officers of Health https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"issue":"5","key":"10.1002\/14651858.CD013672.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1360-0443.1994.tb03332.x","article-title":"Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package","volume":"89","author":"Raistrick","year":"1994","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0056|cit56","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"1","key":"10.1002\/14651858.CD013672.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12954-022-00671-z","article-title":"Opioid agonist treatment take-home doses ('carries'): are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?","volume":"19","author":"Russell","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"9","key":"10.1002\/14651858.CD013672.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Clark","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0059|cit59","doi-asserted-by":"crossref","unstructured":"Spencer MR Garnett MF Mini\u00f1o AM Drug overdose deaths in the United States, 2002\u20132022 Hyattsville (MD): National Center for Health Statistics; 2024 March. NCHS Data Brief, no 491 10.15620\/cdc:135849","DOI":"10.15620\/cdc:135849"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0060|cit60","unstructured":"World Health Organization Primary health care https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/primary-health-care"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0061|cit61","unstructured":"World Health Organization A vision for primary health care in the 21st century https:\/\/www.who.int\/docs\/default-source\/primary-health\/vision.pdf"},{"key":"10.1002\/14651858.CD013672.pub2-BIB0062|cit62","unstructured":"World Health Organization United Nations Office on Drugs and Crime International standards for the treatment of drug use disorders https:\/\/www.who.int\/publications\/i\/item\/international-standards-for-the-treatment-of-drug-use-disorders"},{"issue":"7","key":"10.1002\/14651858.CD013672.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013672","article-title":"Primary care versus specialty care management of opioid use disorder","author":"Perry","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:02:38Z","timestamp":1775620958000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013672.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013672.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}